QuidelOrtho Corporation

QDEL Healthcare Medical Devices

QuidelOrtho Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, down 1.89% from fiscal 2024. In the quarter to June 2026, revenue grew 2.77%, EPS grew 63.9%, free cash flow fell 61.5% and total debt rose 10.9%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

12.94 0.97 −6.97%
Market cap
$953.9M
P/E
0.0×
Fwd P/E
−9.0×
Dividend yield
—
F-score
6/9
Altman Z
0.11
Beneish M
−3.12
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(45.91%) (49.95%) (46.15%) (45.16%)

+8 more TTM periods

Piotroski F-Score
3 4 6 5
ROA
(17.34%) (20.03%) (18.56%) (18.91%)
ROIC
(11.35%) (13.97%) (13.05%) (12.96%)
Return on Tangible Assets
(60.89%) (69.04%) (61.53%) (61.37%)
Average Days of Receivables
48.04 49.44 55.75 51.97
Free Cash Flow per Share
(3.09) (2.34) (1.22) (2.11)
Free Cash Flow
(211.20) (159.40) (83.00) (143.80)
Other line items

Show all line items

Columns are period end dates